首页> 外国专利> Microencapsulated system containing D - fructose - 1,6 - diphosphate to improved analgesic efficacy and anti-inflammatory drug

Microencapsulated system containing D - fructose - 1,6 - diphosphate to improved analgesic efficacy and anti-inflammatory drug

机译:包含D-果糖-1,6-二磷酸的微囊化系统,以提高镇痛作用和抗炎药

摘要

Microencapsulated system containing D - fructose - 1,6 - diphosphate to improved analgesic efficacy and anti flamatu00f3ria drug. The present invention consists in F1, 6BP microencapsulated for modified release of the drug, a product with great prospects for use in therapy in front of many pathologies.This new product, obtained by a process of low cost and without the use of organic solvents by means of microencapsulation of F1, 6BP. In addition, the F1, 6BP is an intermediate in the glycolytic pathway with significant antioxidant activity, analgesic and anti - inflammatory, low cost and free of toxic effects at pharmacologically active doses.
机译:包含D-果糖-1,6-二磷酸的微囊化系统,以改善止痛效果和抗炎药。本发明在于微囊化的F1、6BP,其用于药物的缓释,该产品在许多病理学面前具有广阔的治疗前景。该新产品是通过低成本的方法获得的,并且无需使用有机溶剂。 F1,6BP的微囊化方法。此外,F1、6BP是糖酵解途径中的中间体,具有显着的抗氧化活性,止痛和抗炎作用,价格低廉,并且在药理活性剂量下无毒作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号